Rua Alnoman
Dr Julian Knight
| New quinoline-based BODIPYs as EGFR/VEGFR-2 inhibitors: Molecular docking, DFT and in vitro cytotoxicity on HeLa cells | 2022 |
|
Rua Alnoman
Dr Julian Knight
| Synthesis, Molecular Docking, and DFT Calculation of a Half-Strapped BODIPY as Potential EGFR Inhibitor** | 2020 |
|
Dr Julian Knight
Rua Alnoman
Dr Paul Waddell
| Synthesis of 3-aminoBODIPY dyes via copper-catalyzed vicarious nucleophilic substitution of 2-halogeno derivatives | 2015 |
|
